Trial intelligence / Profile preview

Metformin vs Atorvastatin as Adjuvant Therapy in Non-metastatic Breast Cancer

NCT05507398Phase 4Unknown

Sponsor
Tanta University
Start
Oct 2022
Primary completion
Jul 2023
Modality
Small Molecules
01

Overview

A Phase 4 trial of metformin, atorvastatin in breast cancer, sponsored by Tanta University. Status: unknown.

02

Drugs

metforminatorvastatin
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT05507398.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05507398.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call